Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

EPOKINE - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/EPOKINE

Approved

STANDARD

EPOKINE

HK inno.N CORPORATION🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: b2403028f3d3bc76
Company: HK inno.N CORPORATION
Type: Standard

Approval Details

Approval Id: b2403028f3d3bc76
Drug Approval Philippines Name: EPOKINE
Product Name: EPOKINE
Registration Number: BRP-104
Brand Name: EPOKINE
Generic Name: EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)
Dosage Form: SOLUTION FOR INJECTION (IV/SC)
Dosage Strength: 2,000 IU/ 0.5 mL
Manufacturer: HK inno.N CORPORATION
Importer: MACROPHARMA CORPORATION
Distributor: MACROPHARMA CORPORATION
Company Detail Path: /organization/hk-inno-n-corporation
Issuance Date: 08 July 2022
Expiry Date: 25 July 2027
Pharmacologic Category: HEMATOPOIETIC GROWTH FACTOR
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b2403028f3d3bc76

Type

Standard

Back to Philippines FDA Approvals